Her main research concerns Breast cancer, Internal medicine, Oncology, Cancer and Gynecology. Her Breast cancer research incorporates elements of Prospective cohort study and Genome-wide association study, Single-nucleotide polymorphism. Caroline Seynaeve focuses mostly in the field of Internal medicine, narrowing it down to matters related to Surgery and, in some cases, Mastectomy, Prophylactic Mastectomy and Bilateral Prophylactic Mastectomy.
She has included themes like Cohort study, CHEK2, Cyclophosphamide, Hazard ratio and Survival analysis in her Oncology study. Her studies deal with areas such as Histopathology, Germline mutation and Cancer research as well as Cancer. Her work deals with themes such as Mammography, Confidence interval, Tamoxifen, Physical examination and Risk factor, which intersect with Gynecology.
The scientist’s investigation covers issues in Breast cancer, Internal medicine, Oncology, Cancer and Gynecology. Her Breast cancer research focuses on Estrogen receptor in particular. Her Oncology study integrates concerns from other disciplines, such as Odds ratio, Surgery, Case-control study, Mastectomy and Cohort.
Caroline Seynaeve has researched Cancer in several fields, including Germline mutation and Disease, Incidence, Pathology. Her Gynecology research is multidisciplinary, incorporating elements of Prophylactic Mastectomy, Mammography, Distress, Obstetrics and Risk factor. Her Genome-wide association study research incorporates themes from Genetic association and Genetic predisposition.
Her primary scientific interests are in Breast cancer, Internal medicine, Oncology, Tamoxifen and Hazard ratio. Breast cancer is a subfield of Cancer that she tackles. Caroline Seynaeve usually deals with Internal medicine and limits it to topics linked to Gynecology and Young adult and Prospective cohort study.
The concepts of her Oncology study are interwoven with issues in Odds ratio, Metastatic breast cancer, Ovarian cancer, Estrogen receptor and Adjuvant therapy. Her Tamoxifen research incorporates elements of Randomized controlled trial and Early breast cancer. Her research in Hazard ratio intersects with topics in Discontinuation, Cumulative incidence and Predictive marker.
Caroline Seynaeve focuses on Breast cancer, Internal medicine, Oncology, Genome-wide association study and Hazard ratio. Her Breast cancer research is under the purview of Cancer. Her Cancer research includes elements of Stroke, Magnetic resonance imaging, Radiology and Subclinical infection.
Her Oncology research is multidisciplinary, incorporating perspectives in Odds ratio, Circulating tumor cell, Metastatic breast cancer, Estrogen receptor and Cohort. Her Genome-wide association study research integrates issues from Genetic association and Genetic predisposition. The study incorporates disciplines such as Aromatase inhibitor and Anastrozole in addition to Gynecology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation
Hanne Meijers-Heijboer;Bert van Geel;Wim L.J. van Putten;Sonja C. Henzen-Logmans.
The New England Journal of Medicine (2001)
RAD51B in Familial Breast Cancer
Liisa M. Pelttari;Sofia Khan;Mikko Vuorela;Johanna I. Kiiski.
PLOS ONE (2016)
Association analysis identifies 65 new breast cancer risk loci
Kyriaki Michailidou;Kyriaki Michailidou;Sara Lindström;Sara Lindström;Joe Dennis;Jonathan Beesley.
Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies
Xiaohong R. Yang;Jenny Chang-Claude;Ellen L. Goode;Fergus J. Couch.
Journal of the National Cancer Institute (2011)
MicroRNA related polymorphisms and breast cancer risk
Sofia Khan;Dario Greco;Dario Greco;Kyriaki Michailidou;Roger L. Milne;Roger L. Milne.
PLOS ONE (2014)
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
Stig E. Bojesen;Stig E. Bojesen;Karen A. Pooley;Sharon E. Johnatty;Jonathan Beesley.
Nature Genetics (2013)
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
Nasim Mavaddat;Kyriaki Michailidou;Kyriaki Michailidou;Joe Dennis;Michael Lush.
American Journal of Human Genetics (2019)
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.
Shahana Ahmed;Gilles Thomas;Maya Ghoussaini;Catherine S. Healey.
Nature Genetics (2009)
Micrometastases or Isolated Tumor Cells and the Outcome of Breast Cancer
Maaike de Boer;Carolien H.M. van Deurzen;Jos A.A.M. van Dijck;George F. Borm.
The New England Journal of Medicine (2009)
Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1
LC Verhoog;Ctm Brekelmans;C Seynaeve;Lmc van den Bosch.
The Lancet (1998)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: